Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 693

Similar articles for PubMed (Select 19489656)

1.

Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.

Ingram JR, Martin JA, Finlay AY.

Am J Clin Dermatol. 2009;10(4):229-37. doi: 10.2165/00128071-200910040-00003. Review.

PMID:
19489656
2.

Efficacy of Topical Calcineurin Inhibitors in Oral Lichen Planus.

Sotoodian B, Lo J, Lin A.

J Cutan Med Surg. 2015 Jun 18. pii: 1203475415591936. [Epub ahead of print] Review.

PMID:
26088501
3.

Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis.

Chia BK, Tey HL.

Dermatitis. 2015 May-Jun;26(3):122-32. doi: 10.1097/DER.0000000000000118.

PMID:
25984688
4.

Hand Dermatitis: A Review of Clinical Features, Prevention and Treatment.

Antonov D, Schliemann S, Elsner P.

Am J Clin Dermatol. 2015 Apr 29. [Epub ahead of print]

PMID:
25920436
5.

Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis.

Legendre L, Barnetche T, Mazereeuw-Hautier J, Meyer N, Murrell D, Paul C.

J Am Acad Dermatol. 2015 Jun;72(6):992-1002. doi: 10.1016/j.jaad.2015.02.1116. Epub 2015 Apr 1.

PMID:
25840730
6.

A Reassuring Rejoinder Against Malignant Influences of Topical Calcineurin Use in Children.

Hanifin JM.

JAMA Dermatol. 2015 Jun 1;151(6):587-8. doi: 10.1001/jamadermatol.2014.4306. No abstract available.

PMID:
25692944
7.

Functional interpretation of metabolomics data as a new method for predicting long-term side effects: treatment of atopic dermatitis in infants.

Lee SJ, Woo SI, Ahn SH, Lim DK, Hong JY, Park JH, Lim J, Kim MK, Kwon SW.

Sci Rep. 2014 Dec 10;4:7408. doi: 10.1038/srep07408.

8.

Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.

Lerche CM, Wulf HC.

Dermatol Reports. 2010 Sep 14;2(2):e13. doi: 10.4081/dr.2010.e13. eCollection 2010 Aug 31. Review.

9.

Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.

Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Eichenfield LF.

J Am Acad Dermatol. 2014 Dec;71(6):1218-33. doi: 10.1016/j.jaad.2014.08.038. Epub 2014 Sep 26.

PMID:
25264237
10.

Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors.

Shi VY, Joo JS, Sharon VR.

Dermatol Online J. 2014 Aug 17;20(8). pii: 13030/qt45k792vj.

PMID:
25148283
11.

An update on current pharmacotherapy options in atopic dermatitis.

Reitamo S, Remitz A.

Expert Opin Pharmacother. 2014 Aug;15(11):1517-24. doi: 10.1517/14656566.2014.915941. Epub 2014 May 8. Review.

PMID:
24811606
12.

Optimizing outcomes for paediatric atopic dermatitis.

Eichenfield LF, Totri C.

Br J Dermatol. 2014 Jul;170 Suppl 1:31-7. doi: 10.1111/bjd.12976. Epub 2014 May 9. Review.

PMID:
24720616
13.

Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis.

Wan XC, Dimov V.

Expert Opin Drug Metab Toxicol. 2014 Apr;10(4):543-9. doi: 10.1517/17425255.2014.884070. Epub 2014 Feb 3. Review.

PMID:
24490943
14.

Therapeutic efficacy of topical calcineurin inhibitors in plasma cell balanitis: case series and review of the literature.

Kyriakou A, Patsatsi A, Patsialas C, Sotiriadis D.

Dermatology. 2014;228(1):18-23. doi: 10.1159/000357153. Epub 2014 Jan 9. Review.

PMID:
24434685
15.

Efficacy of topical calcineurin inhibitors in psoriasis.

Wang C, Lin A.

J Cutan Med Surg. 2014 Jan-Feb;18(1):8-14. Review.

PMID:
24377467
16.

The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis.

Danby SG, Chittock J, Brown K, Albenali LH, Cork MJ.

Br J Dermatol. 2014 Apr;170(4):914-21. doi: 10.1111/bjd.12778.

PMID:
24328907
17.

Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use.

Gutfreund K, Bienias W, Szewczyk A, Kaszuba A.

Postepy Dermatol Alergol. 2013 Jun;30(3):165-9. doi: 10.5114/pdia.2013.35619. Epub 2013 Jun 20. Review.

18.

Off-label topical calcineurin inhibitor use in children.

Manthripragada AD, Pinheiro SP, MaCurdy TE, Saneinejad S, Worrall CM, Kelman JA, Graham DJ.

Pediatrics. 2013 Nov;132(5):e1327-32. doi: 10.1542/peds.2013-0931. Epub 2013 Oct 14.

19.
20.

Jessner-Kanof disease: two effective and sure therapeutic options.

Conti R, Bassi A, Lorenzoni E, Bruscino N, Scatena C, Bonan P, Cannarozzo G, Moretti S, Campolmi P.

Dermatol Ther. 2013 Jul-Aug;26(4):373-6. doi: 10.1111/dth.12005.

PMID:
23914897
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk